This can be accomplishing using mitotic counts and the Ki-67 proliferation marker. So don't go there, until you have reached the end of your appeals with the insurer directly.Īt the time of diagnosis, it is essential to ascertain the grade for neuroendocrine tumors (NETs), since response in high-grade disease is substantially inferior, notes Rodney F. The State's Independent Medical Review is FINAL. His response was "Any prudent person would do what she did". The State sent my appeal to a radiologist who did his own research on my cancer and the treatment. They determined the PRRT treatment met the "prudent layperson criteria for urgently needed services"
But the State of California defines "urgently needed services" as those necessary to prevent serious deteriorating of the health of a patient, resulting from an unforeseen illness, injury, or complication of an existing condition, including pregnancy, for which treatment cannot be delayed until the enrollee returns to the plan's service area." My Blue Shield HMO says they only pay for "emergency" treatments overseas. And pointed out that if I had breast cancer, I'd have chemo and Blue Shield wouldn't have blinked. I sent a letter on PRRT that the hospital in Switzerland had given to me. I sent in all my documents with a personal letter explaining that it was not chemo. After exhausting my appeals with Blue Shield, I went to the State and asked for an "Independent Medical Review". They kept sending denial letters saying "chemo wasn't an emergency". I fought with Blue Shield HMO for reimbursement for that entire year and a half. My tumors didn't grow for a year and a half. It's been done there for over ten years, is well tolerated and a big help. A special radiation treatment done in Europe but not currently available in the USA. I went to Switzerland twice in 2013 for (PRRT). I have neuroendocrine cancer, a rare type of cancer that is chemo resistant with very few treatment options. The results will be presented in table form - if you wish to map the centers - select Map these contacts above the Name column.īy Myna - NorCal CarciNET Community Member Once you have done this, click on the select button at the bottom of the page. You may enter search information or leave it blank. You will be presented with a search tool. To use the tool - please click here or on the MAP image.
#NETSPOT NOVARTIS REGISTRATION#
Please note the reader training requires registration at the SNMMI website.
#NETSPOT NOVARTIS HOW TO#
To learn about how to read a NETSPOT image, click here for SNMMI NETSPOT reader training. To learn more about Ga68 and Theranostics, please visit our video channel from the 3rd Theranostics World Congress. If you like this service, please consider donating to NorCal CarciNET so we can continue to provide and maintain our services. This tool is offered as a public service - to inform us of inaccuracies, new locations or provide us contact information for a location - please This email address is being protected from spambots. PLEASE confirm coverage with insurer prior to the scan. Medicare does provide coverage for NETSPOT but not all private insurance does. Please work with your physician to determine if this diagnostic test is correct for you.Īs of Jthe FDA approved Ga68 DotaTate Scan (NETSPOT (tm)) for Neuroendocrine Tumors.īefore you go for your scan confirm how the scan will be paid for. This tool is not a recommendation for treatment or diagnostic test. The MAP image is not a current image as data is updated weekly.
#NETSPOT NOVARTIS TRIAL#
For the most up to date trial information please see. We have included some trial locations as well. This search tool/map is to help patients and physicians identify which centers are currently offering Ga68 PET/CT, PET/MRI and PRRT for either Neuroendocrine Tumors or Prostate Cancer.
0 kommentar(er)
